Coronavirus (Covid-19): Latest updates and information
Skip to main content Skip to navigation

News


Select tags to filter on

Cell-Freezing Market to be transformed by University of Warwick Spin-Out CryoLogyx

The University of Warwick spin-out company, CryoLogyx, has been awarded £300k from InnovateUK to develop innovate cryopreservation agents with applications in the diagnostic, medicines discovery and cell-based therapy markets.

For commercial enquiries contact Dr James Lapworth, Warwick Innovations, email: j.lapworth@warwick.ac.uk, tel: + 44 (0)2476 575481

Thu 11 Feb 2021, 11:55 | Tags: Life Sciences and Biotechnology, Warwick Innovations